NCT00604539 - Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

November 30, 2009

Conditions

SynovitisOsteoarthritisJoint DiseasesMuskuloskeletal Diseases

Interventions

DRUG

Chondroitin sulphate (Condrosan)

800 mg (two capsules of 400 mg each) taken once a day for one year

DRUG

Placebo

Two placebo capsules taken once a day for six months followed by an additional six month treatment of 800 mg (two capsules of 400 mg of Chondroitin sulphate each) taken once a day

Trial Locations (4)

H2L 1S6

Inst. De Rhumatologie, Montreal

G1V 3M7

Groupe de recherche en rhumatologie et maladies osseuses, Ste-Foy

G1W 4R4

Centre de rhumatologie St-Louis, Ste-Foy

G8A 1Y2

Centre de recherche musculo-squelettique, Trois-Rivières